Rani Therapeutics Holdings, Inc. RANI
0.58 USD -0.07 (-10.42%)
Regular-session close
0.59 +0.01 +1.62%
Pre-market · Nov 20, 4:00 AM ET
0.56 Day range 0.6503
0.502 52-week range 1.82
- YTD
- -56.99%
- 1 year
- -66.82%
Analyst view
Price target (mean) 11.50 +1880.7% upside
Now 0.5806
- Target (low)
- 8.00
- Target (mean)
- 11.50
- Target (high)
- 17.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy2
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Included in Essentials and up
Sign in to see Revenue and earnings forecast
Reported revenue and earnings per share by year, then what analysts expect next.
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.22667 | -0.28 – -0.17 | -0.27 | +16.0% | 0 | 0.0% | 3 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -1.01 | -1.06 – -0.96 | -1.33 | +23.9% | 0 | 0.0% | 4 |
| Next year | -0.77796 | -0.90182 – -0.59 | -1.01 | +23.2% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 16, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 2, 2024 | Oppenheimer | Initiated | — | Outperform |
| Jun 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 14, 2024 | Maxim Group | Initiated | — | Buy |
| Jun 13, 2024 | Rodman & Renshaw | Initiated | — | Buy |
| May 9, 2024 | BTIG | Maintained | Buy | Buy |
| May 7, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 27, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 25, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 6, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Nov 9, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 20, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 8, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 21, 2023 | B of A Securities | Maintained | Buy | Buy |
| Aug 17, 2023 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 14, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 6, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 23, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Oct 11, 2022 | UBS | Initiated | — | Buy |
| Jul 27, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Jun 13, 2022 | Wedbush | Initiated | — | Outperform |
| Aug 25, 2021 | BTIG | Initiated | — | Buy |
| Aug 24, 2021 | B of A Securities | Initiated | — | Buy |
| Aug 24, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |
| Aug 24, 2021 | Stifel | Initiated | — | Buy |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.
